Results 21 to 30 of about 50,080 (291)

Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastropathy in Patients With Chronic Arthritis? [PDF]

open access: yes, 1994
Whether misoprostol, a synthetic prostaglandin E1 analogue, should be routinely prescribed along with nonsteriodal anti-inflammatory drugs (NSAIDS) to prevent gastric damage is of great clinical importance and has profound cost implications. No consensus
Johannesson, Magnus   +2 more
core   +1 more source

A double-blind randomized controlled trial of two different doses of misoprostol for cervical priming prior to office hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2015
Objective: To evaluate and compare the effectiveness of 200 μg vaginal misoprostol vs. 400 μg vaginal misoprostol administrated 3 h prior to office hysteroscopy, in cervical priming. Design: Randomized controlled trial.
Waleed El-Khayat   +3 more
doaj   +1 more source

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

open access: yesPLoS ONE, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect
Dustin L Cooper   +11 more
doaj   +1 more source

Safety and efficacy of double-balloon catheter for cervical ripening: a Bayesian network meta-analysis of randomized controlled trials

open access: yesBMC Pregnancy and Childbirth, 2022
Background Various methods are used for cervical ripening during the induction of labor. Mechanical and pharmacological methods are commonly used for cervical ripening.
Ge Zhao, Guang Song, Jing Liu
doaj   +1 more source

Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report

open access: yesNovelty in Biomedicine, 2022
Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj   +1 more source

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention. [PDF]

open access: yes, 2014
BackgroundBangladesh is one of the few countries that may actually achieve the fifth Millennium Development Goal (MDG) in time, despite skilled birth attendance remaining low.
Bell, Suzanne   +2 more
core   +1 more source

An audit of oral administration of Angusta® (misoprostol) 25 µg for induction of labor in 976 consecutive women with a singleton pregnancy in a university hospital in Denmark

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2020
Induction of labor (IOL) is used to improve the outcome of pregnancy for mother and child. Since 2013, oral misoprostol has been used for IOL at Aarhus University Hospital, Denmark.
R. Helmig, L. Hvidman
semanticscholar   +1 more source

Comprehensive abortion care: evidence of improvements in hospital-level indicators in Tigray, Ethiopia. [PDF]

open access: yes, 2013
ObjectiveApproximately 18% of maternal deaths in East Africa is attributable to unsafe abortion. Availability of comprehensive abortion care (CAC) services at all levels of the healthcare system, including medical abortion, has the potential to increase ...
Bell, Suzanne   +2 more
core   +2 more sources

Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review.

open access: yesObstetrics and Gynecology, 2019
OBJECTIVE To summarize available data on the effectiveness and safety of single-agent misoprostol for medical abortion in the first trimester. DATA SOURCES We searched MEDLINE, CABI, Cochrane, EMBASE, LILACS, the Web of Science, and ClinicalTrials.gov ...
E. Raymond, Margo S. Harrison, M. Weaver
semanticscholar   +1 more source

A comparative study between isosorbide mononitrate (IMN) versus misoprostol prior to hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2010
Objective: To compare the efficacy of a nitric oxide donor (isosorbide mononitrate) and a prostaglandin E1 analogue (misoprostol) for cervical priming before hysteroscopy. Design: Comparative clinical trial.
Waleed El-Khayat   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy